Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. nature immunology 
3. review articles 
4. article
•  Review Article
•  Published: 20 April 2010


The role of pattern-recognition
receptors in innate immunity:
update on Toll-like receptors
•  Taro Kawai1,2 &
•  Shizuo Akira
1,2 
Nature Immunology volume 11, pages 373–384 (2010)Cite this
article
•  100k Accesses
•  7939 Citations
•  58 Altmetric
•  Metrics details
Subjects
•  Immunological disorders
•  Innate immunity
•  Signal transduction
•  Toll-like receptors
Abstract
The discovery of Toll-like receptors (TLRs) as components that
recognize conserved structures in pathogens has greatly advanced
understanding of how the body senses pathogen invasion, triggers
innate immune responses and primes antigen-specific adaptive
immunity. Although TLRs are critical for host defense, it has
become apparent that loss of negative regulation of TLR signaling,
as well as recognition of self molecules by TLRs, are strongly
associated with the pathogenesis of inflammatory and autoimmune
diseases. Furthermore, it is now clear that the interaction between


TLRs and recently identified cytosolic innate immune sensors is
crucial for mounting effective immune responses. Here we describe
the recent advances that have been made by research into the role
of TLR biology in host defense and disease.
 Access through your institution
Buy or subscribe
This is a preview of subscription content, access via your institution
Access options
 Access through your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Learn more
Buy this article
•  Purchase on SpringerLink
•  Instant access to full article PDF
Buy now
Prices may be subject to local taxes which are calculated during
checkout
Additional access options:
•  Log in
•  Learn about institutional subscriptions
•  Read our FAQs
•  Contact customer support


Figure 1: PAMP recognition by cell surface TLRs.
[image]
Figure 2: PAMP recognition by intracellular TLRs.
[image]
Figure 3: Overview of TLR signaling pathways.
[image]
Figure 4: Endogenous agonists for TLRs and immune diseases.
[image]
Similar content being viewed by others
[image]
Exploiting viral sensing mediated by Toll-like
receptors to design innovative vaccines
Article Open access 28 October 2021
[image]
Label-free biosensor assay decodes the dynamics of
Toll-like receptor signaling
Article Open access 12 November 2024
[image]
Discovery of ETI41 and ETI60: novel selective
endosomal Toll-like receptor inhibitors for the
treatment of autoimmune diseases
Article Open access 01 September 2025
References
1. Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical
proteins linking innate and acquired immunity. Nat. Immunol.
2, 675–680 (2001).
CAS  PubMed  Google Scholar 


2. Janeway, C.A. Jr. & Medzhitov, R. Innate immune
recognition. Annu. Rev. Immunol. 20, 197–216 (2002).
Article  CAS  PubMed  Google Scholar 
3. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition
and innate immunity. Cell 124, 783–801 (2006).
Article  CAS  PubMed  Google Scholar 
4. Jin, M.S. & Lee, J.O. Structures of the Toll-like receptor
family and its ligand complexes. Immunity 29, 182–191
(2008).
CAS  PubMed  Google Scholar 
5. Kawai, T. & Akira, S. Innate immune recognition of viral
infection. Nat. Immunol. 7, 131–137 (2006).
CAS  PubMed  Google Scholar 
6. Barbalat, R., Lau, L., Locksley, R.M. & Barton, G.M. Toll-like
receptor 2 on inflammatory monocytes induces type I
interferon in response to viral but not bacterial ligands. Nat.
Immunol. 10, 1200–1207 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
7. Yoneyama, M. & Fujita, T. RNA recognition and signal
transduction by RIG-I-like receptors. Immunol. Rev. 227, 54–
65 (2009).
CAS  PubMed  Google Scholar 
8. Franchi, L., Eigenbrod, T., Munoz-Planillo, R. & Nunez, G.
The inflammasome: a caspase-1-activation platform that
regulates immune responses and disease pathogenesis. Nat.
Immunol. 10, 241–247 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
9. Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes:


guardians of the body. Annu. Rev. Immunol. 27, 229–265
(2009).
CAS  PubMed  Google Scholar 
10. Ishii, K.J. et al. A Toll-like receptor-independent antiviral
response induced by double-stranded B-form DNA. Nat.
Immunol. 7, 40–48 (2006).
CAS  PubMed  Google Scholar 
11. Stetson, D.B. & Medzhitov, R. Recognition of cytosolic DNA
activates an IRF3-dependent innate immune response.
Immunity 24, 93–103 (2006).
CAS  PubMed  Google Scholar 
12. Akashi-Takamura, S. & Miyake, K. TLR accessory molecules.
Curr. Opin. Immunol. 20, 420–425 (2008).
CAS  PubMed  Google Scholar 
13. Kim, H.M. et al. Crystal structure of the TLR4-MD-2 complex
with bound endotoxin antagonist Eritoran. Cell 130, 906–917
(2007).
CAS  PubMed  Google Scholar 
14. Park, B.S. et al. The structural basis of lipopolysaccharide
recognition by the TLR4-MD-2 complex. Nature 458, 1191–
1195 (2009).
CAS  PubMed  Google Scholar 
15. Jin, M.S. et al. Crystal structure of the TLR1–TLR2
heterodimer induced by binding of a tri-acylated lipopeptide.
Cell 130, 1071–1082 (2007).
CAS  PubMed  Google Scholar 
16. Kang, J.Y. et al. Recognition of lipopeptide patterns by Toll-
like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31,


873–884 (2009).
CAS  PubMed  Google Scholar 
17. Hoebe, K. et al. CD36 is a sensor of diacylglycerides. Nature
433, 523–527 (2005).
CAS  PubMed  Google Scholar 
18. Goodridge, H.S. & Underhill, D.M. Fungal recognition by
TLR2 and dectin-1. Handb. Exp. Pharmacol. 183, 87–109
(2008).
CAS  Google Scholar 
19. Uematsu, S. et al. Regulation of humoral and cellular gut
immunity by lamina propria dendritic cells expressing Toll-
like receptor 5. Nat. Immunol. 9, 769–776 (2008).
CAS  PubMed  Google Scholar 
20. Zhang, D. et al. A toll-like receptor that prevents infection by
uropathogenic bacteria. Science 303, 1522–1526 (2004).
CAS  PubMed  Google Scholar 
21. Yarovinsky, F. et al. TLR11 activation of dendritic cells by a
protozoan profilin-like protein. Science 308, 1626–1629
(2005).
CAS  PubMed  Google Scholar 
22. Choe, J., Kelker, M.S. & Wilson, I.A. Crystal structure of
human Toll-like receptor 3 (TLR3) ectodomain. Science 309,
581–585 (2005).
CAS  PubMed  Google Scholar 
23. Bell, J.K., Askins, J., Hall, P.R., Davies, D.R. & Segal, D.M.
The dsRNA binding site of human Toll-like receptor 3. Proc.
Natl. Acad. Sci. USA 103, 8792–8797 (2006).


CAS  PubMed  PubMed Central  Google Scholar 
24. Kawai, T. & Akira, S. Toll-like receptor and RIG-I-like
receptor signaling. Ann. NY Acad. Sci. 1143, 1–20 (2008).
CAS  PubMed  Google Scholar 
25. Tabeta, K. et al. Toll-like receptors 9 and 3 as essential
components of innate immune defense against mouse
cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101,
3516–3521 (2004).
CAS  PubMed  PubMed Central  Google Scholar 
26. Zhang, S.Y. et al. TLR3 deficiency in patients with herpes
simplex encephalitis. Science 317, 1522–1527 (2007).
CAS  PubMed  Google Scholar 
27. Hornung, V. et al. Sequence-specific potent induction of IFN-
α by short interfering RNA in plasmacytoid dendritic cells
through TLR7. Nat. Med. 11, 263–270 (2005).
CAS  PubMed  Google Scholar 
28. Mancuso, G. et al. Bacterial recognition by TLR7 in the
lysosomes of conventional dendritic cells. Nat. Immunol. 10,
587–594 (2009).
CAS  PubMed  Google Scholar 
29. Lee, H.K., Lund, J.M., Ramanathan, B., Mizushima, N. &
Iwasaki, A. Autophagy-dependent viral recognition by
plasmacytoid dendritic cells. Science 315, 1398–1401 (2007).
CAS  PubMed  Google Scholar 
30. Haas, T. et al. The DNA sugar backbone 2′ deoxyribose
determines Toll-like receptor 9 activation. Immunity 28, 315–
323 (2008).
CAS  PubMed  Google Scholar 


31. Coban, C. et al. Immunogenicity of whole-parasite vaccines
against Plasmodium falciparum involves malarial hemozoin
and host TLR9. Cell Host Microbe 7, 50–61 (2010).
CAS  PubMed  Google Scholar 
32. Kim, Y.M., Brinkmann, M.M., Paquet, M.E. & Ploegh, H.L.
UNC93B1 delivers nucleotide-sensing toll-like receptors to
endolysosomes. Nature 452, 234–238 (2008).
CAS  PubMed  Google Scholar 
33. Tabeta, K. et al. The Unc93b1 mutation 3d disrupts
exogenous antigen presentation and signaling via Toll-like
receptors 3, 7 and 9. Nat. Immunol. 7, 156–164 (2006).
CAS  PubMed  Google Scholar 
34. Casrouge, A. et al. Herpes simplex virus encephalitis in
human UNC-93B deficiency. Science 314, 308–312 (2006).
CAS  PubMed  Google Scholar 
35. Brinkmann, M.M. et al. The interaction between the ER
membrane protein UNC93B and TLR3, 7, and 9 is crucial for
TLR signaling. J. Cell Biol. 177, 265–275 (2007).
CAS  PubMed  PubMed Central  Google Scholar 
36. Kiyokawa, T. et al. A single base mutation in the PRAT4A
gene reveals differential interaction of PRAT4A with Toll-like
receptors. Int. Immunol. 20, 1407–1415 (2008).
CAS  PubMed  Google Scholar 
37. Takahashi, K. et al. A protein associated with Toll-like
receptor (TLR) 4 (PRAT4A) is required for TLR-dependent
immune responses. J. Exp. Med. 204, 2963–2976 (2007).
CAS  PubMed  PubMed Central  Google Scholar 
38. Yang, Y. et al. Heat shock protein gp96 is a master chaperone


for Toll-like receptors and is important in the innate function
of macrophages. Immunity 26, 215–226 (2007).
PubMed  PubMed Central  Google Scholar 
39. Ewald, S.E. et al. The ectodomain of Toll-like receptor 9 is
cleaved to generate a functional receptor. Nature 456, 658–
662 (2008).
CAS  PubMed  PubMed Central  Google Scholar 
40. Park, B. et al. Proteolytic cleavage in an endolysosomal
compartment is required for activation of Toll-like receptor 9.
Nat. Immunol. 9, 1407–1414 (2008).
CAS  PubMed  PubMed Central  Google Scholar 
41. Asagiri, M. et al. Cathepsin K-dependent Toll-like receptor 9
signaling revealed in experimental arthritis. Science 319, 624–
627 (2008).
CAS  PubMed  Google Scholar 
42. Matsumoto, F. et al. Cathepsins are required for Toll-like
receptor 9 responses. Biochem. Biophys. Res. Commun. 367,
693–699 (2008).
CAS  PubMed  Google Scholar 
43. Sepulveda, F.E. et al. Critical role for asparagine
endopeptidase in endocytic Toll-like receptor signaling in
dendritic cells. Immunity 31, 737–748 (2009).
CAS  PubMed  Google Scholar 
44. Peter, M.E., Kubarenko, A.V., Weber, A.N. & Dalpke, A.H.
Identification of an N-terminal recognition site in TLR9 that
contributes to CpG-DNA-mediated receptor activation. J.
Immunol. 182, 7690–7697 (2009).
CAS  PubMed  Google Scholar 


45. Kagan, J.C. & Medzhitov, R. Phosphoinositide-mediated
adaptor recruitment controls Toll-like receptor signaling. Cell
125, 943–955 (2006).
CAS  PubMed  Google Scholar 
46. Rowe, D.C. et al. The myristoylation of TRIF-related adaptor
molecule is essential for Toll-like receptor 4 signal
transduction. Proc. Natl. Acad. Sci. USA 103, 6299–6304
(2006).
CAS  PubMed  PubMed Central  Google Scholar 
47. Kagan, J.C. et al. TRAM couples endocytosis of Toll-like
receptor 4 to the induction of interferon-β. Nat. Immunol. 9,
361–368 (2008).
CAS  PubMed  PubMed Central  Google Scholar 
48. Tanimura, N., Saitoh, S., Matsumoto, F., Akashi-Takamura, S.
& Miyake, K. Roles for LPS-dependent interaction and
relocation of TLR4 and TRAM in TRIF-signaling. Biochem.
Biophys. Res. Commun. 368, 94–99 (2008).
CAS  PubMed  Google Scholar 
49. Kawagoe, T. et al. Sequential control of Toll-like receptor–
dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9,
684–691 (2008).
CAS  PubMed  Google Scholar 
50. Bhoj, V.G. & Chen, Z.J. Ubiquitylation in innate and adaptive
immunity. Nature 458, 430–437 (2009).
CAS  PubMed  Google Scholar 
51. Yamamoto, M. et al. Key function for the Ubc13 E2 ubiquitin-
conjugating enzyme in immune receptor signaling. Nat.
Immunol. 7, 962–970 (2006).
CAS  PubMed  Google Scholar 


52. Tokunaga, F. et al. Involvement of linear polyubiquitylation
of NEMO in NF-κB activation. Nat. Cell Biol. 11, 123–132
(2009).
CAS  PubMed  Google Scholar 
53. Rahighi, S. et al. Specific recognition of linear ubiquitin
chains by NEMO is important for NF-κB activation. Cell 136,
1098–1109 (2009).
CAS  PubMed  Google Scholar 
54. Lo, Y.C. et al. Structural basis for recognition of diubiquitins
by NEMO. Mol. Cell 33, 602–615 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
55. Yamamoto, M. et al. Regulation of Toll/IL-1-receptor-
mediated gene expression by the inducible nuclear protein
IκBζ. Nature 430, 218–222 (2004).
CAS  PubMed  Google Scholar 
56. Litvak, V. et al. Function of C/EBPδ in a regulatory circuit
that discriminates between transient and persistent TLR4-
induced signals. Nat. Immunol. 10, 437–443 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
57. Kuwata, H. et al. IκBNS inhibits induction of a subset of Toll-
like receptor-dependent genes and limits inflammation.
Immunity 24, 41–51 (2006).
CAS  PubMed  Google Scholar 
58. Gilchrist, M. et al. Systems biology approaches identify ATF3
as a negative regulator of Toll-like receptor 4. Nature 441,
173–178 (2006).
CAS  PubMed  Google Scholar 
59. Pobezinskaya, Y.L. et al. The function of TRADD in signaling


through tumor necrosis factor receptor 1 and TRIF-dependent
Toll-like receptors. Nat. Immunol. 9, 1047–1054 (2008).
CAS  PubMed  PubMed Central  Google Scholar 
60. Ermolaeva, M.A. et al. Function of TRADD in tumor necrosis
factor receptor 1 signaling and in TRIF-dependent
inflammatory responses. Nat. Immunol. 9, 1037–1046 (2008).
CAS  PubMed  Google Scholar 
61. Chang, M., Jin, W. & Sun, S.C. Peli1 facilitates TRIF-
dependent Toll-like receptor signaling and proinflammatory
cytokine production. Nat. Immunol. 10, 1089–1095 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
62. Hacker, H. & Karin, M. Regulation and function of IKK and
IKK-related kinases. Sci. STKE 357, re13 (2006).
Google Scholar 
63. Hacker, H. et al. Specificity in Toll-like receptor signalling
through distinct effector functions of TRAF3 and TRAF6.
Nature 439, 204–207 (2006).
PubMed  Google Scholar 
64. Oganesyan, G. et al. Critical role of TRAF3 in the Toll-like
receptor-dependent and -independent antiviral response.
Nature 439, 208–211 (2006).
CAS  PubMed  Google Scholar 
65. Tseng, P.H. et al. Different modes of ubiquitination of the
adaptor TRAF3 selectively activate the expression of type I
interferons and proinflammatory cytokines. Nat. Immunol. 11,
70–75 (2010).
CAS  PubMed  Google Scholar 
66. Wang, C. et al. The E3 ubiquitin ligase Nrdp1 'preferentially'


promotes TLR-mediated production of type I interferon. Nat.
Immunol. 10, 744–752 (2009).
CAS  PubMed  Google Scholar 
67. Shinohara, M.L. et al. Osteopontin expression is essential for
interferon-α production by plasmacytoid dendritic cells. Nat.
Immunol. 7, 498–506 (2006).
CAS  PubMed  PubMed Central  Google Scholar 
68. Cao, W. et al. Toll-like receptor-mediated induction of type I
interferon in plasmacytoid dendritic cells requires the
rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat.
Immunol. 9, 1157–1164 (2008).
CAS  PubMed  PubMed Central  Google Scholar 
69. Takaoka, A. et al. Integral role of IRF-5 in the gene induction
programme activated by Toll-like receptors. Nature 434, 243–
249 (2005).
CAS  PubMed  Google Scholar 
70. Tsujimura, H. et al. Toll-like receptor 9 signaling activates
NF-κB through IFN regulatory factor-8/IFN consensus
sequence binding protein in dendritic cells. J. Immunol. 172,
6820–6827 (2004).
CAS  PubMed  Google Scholar 
71. Honda, K. et al. Spatiotemporal regulation of MyD88-IRF-7
signalling for robust type-I interferon induction. Nature 434,
1035–1040 (2005).
CAS  PubMed  Google Scholar 
72. Palsson-McDermott, E.M. et al. TAG, a splice variant of the
adaptor TRAM, negatively regulates the adaptor MyD88–
independent TLR4 pathway. Nat. Immunol. 10, 579–586
(2009).


CAS  PubMed  Google Scholar 
73. Carty, M. et al. The human adaptor SARM negatively
regulates adaptor protein TRIF-dependent Toll-like receptor
signaling. Nat. Immunol. 7, 1074–1081 (2006).
CAS  PubMed  Google Scholar 
74. Shi, M. et al. TRIM30α negatively regulates TLR-mediated
NF-κB activation by targeting TAB2 and TAB3 for
degradation. Nat. Immunol. 9, 369–377 (2008).
CAS  PubMed  Google Scholar 
75. Tanaka, T., Grusby, M.J. & Kaisho, T. PDLIM2-mediated
termination of transcription factor NF-κB activation by
intranuclear sequestration and degradation of the p65
subunit. Nat. Immunol. 8, 584–591 (2007).
CAS  PubMed  Google Scholar 
76. Kayagaki, N. et al. DUBA: a deubiquitinase that regulates type
I interferon production. Science 318, 1628–1632 (2007).
CAS  PubMed  Google Scholar 
77. Taganov, K.D., Boldin, M.P., Chang, K.J. & Baltimore, D. NF-
κB-dependent induction of microRNA miR-146, an inhibitor
targeted to signaling proteins of innate immune responses.
Proc. Natl. Acad. Sci. USA 103, 12481–12486 (2006).
CAS  PubMed  PubMed Central  Google Scholar 
78. Sheedy, F.J. et al. Negative regulation of TLR4 via targeting
of the proinflammatory tumor suppressor PDCD4 by the
microRNA miR-21. Nat. Immunol. 11, 141–147 (2010).
CAS  PubMed  Google Scholar 
79. Kawagoe, T. et al. TANK is a negative regulator of Toll-like
receptor signaling and is critical for the prevention of
autoimmune nephritis. Nat. Immunol. 10, 965–972 (2009).


CAS  PubMed  PubMed Central  Google Scholar 
80. Hampe, J. et al. A genome-wide association scan of
nonsynonymous SNPs identifies a susceptibility variant for
Crohn disease in ATG16L1. Nat. Genet. 39, 207–211 (2007).
CAS  PubMed  Google Scholar 
81. Saitoh, T. et al. Loss of the autophagy protein Atg16L1
enhances endotoxin-induced IL-1beta production. Nature 456,
264–268 (2008).
CAS  PubMed  Google Scholar 
82. Cadwell, K. et al. A key role for autophagy and the autophagy
gene Atg16l1 in mouse and human intestinal Paneth cells.
Nature 456, 259–263 (2008).
CAS  PubMed  PubMed Central  Google Scholar 
83. Matsushita, K. et al. Zc3h12a is an RNase essential for
controlling immune responses by regulating mRNA decay.
Nature 458, 1185–1190 (2009).
CAS  PubMed  Google Scholar 
84. Carrick, D.M., Lai, W.S. & Blackshear, P.J. The tandem CCCH
zinc finger protein tristetraprolin and its relevance to
cytokine mRNA turnover and arthritis. Arthritis Res. Ther. 6,
248–264 (2004).
CAS  PubMed  PubMed Central  Google Scholar 
85. Turer, E.E. et al. Homeostatic MyD88-dependent signals cause
lethal inflammation in the absence of A20. J. Exp. Med. 205,
451–464 (2008).
CAS  PubMed  PubMed Central  Google Scholar 
86. Croker, B.A. et al. Inflammation and autoimmunity caused by
a SHP1 mutation depend on IL-1, MyD88, and a microbial
trigger. Proc. Natl. Acad. Sci. USA 105, 15028–15033 (2008).


CAS  PubMed  PubMed Central  Google Scholar 
87. An, H. et al. Phosphatase SHP-1 promotes TLR- and RIG-I-
activated production of type I interferon by inhibiting the
kinase IRAK1. Nat. Immunol. 9, 542–550 (2008).
CAS  PubMed  Google Scholar 
88. Ishikawa, H., Ma, Z. & Barber, G.N. STING regulates
intracellular DNA-mediated, type I interferon-dependent
innate immunity. Nature 461, 788–792 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
89. Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA
sensor and an activator of innate immune response. Nature
448, 501–505 (2007).
CAS  PubMed  Google Scholar 
90. Ishii, K.J. et al. TANK-binding kinase-1 delineates innate and
adaptive immune responses to DNA vaccines. Nature 451,
725–729 (2008).
CAS  PubMed  Google Scholar 
91. Hornung, V. & Latz, E. Intracellular DNA recognition. Nat.
Rev. Immunol. 10, 123–130 (2010).
CAS  PubMed  Google Scholar 
92. Fernandes-Alnemri, T. et al. The AIM2 inflammasome is
critical for innate immunity to Francisella tularensis. Nat.
Immunol. advance online publication, doi:10.1038/ni1859 (28
March 2010).
93. Rathinam, V.A. et al. The AIM2 inflammasome is essential for
host defense against cytosolic bacteria and DNA viruses. Nat.
Immunol. advance online publication, doi:10.1038/ni.1864
(29 March 2010).
94. Okabe, Y., Sano, T. & Nagata, S. Regulation of the innate


immune response by threonine-phosphatase of Eyes absent.
Nature 460, 520–524 (2009).
CAS  PubMed  Google Scholar 
95. Koyama, S. et al. Differential role of TLR- and RLR-signaling
in the immune responses to influenza A virus infection and
vaccination. J. Immunol. 179, 4711–4720 (2007).
CAS  PubMed  Google Scholar 
96. Jung, A. et al. Lymphocytoid choriomeningitis virus activates
plasmacytoid dendritic cells and induces a cytotoxic T-cell
response via MyD88. J. Virol. 82, 196–206 (2008).
CAS  PubMed  Google Scholar 
97. Allen, I.C. et al. The NLRP3 inflammasome mediates in vivo
innate immunity to influenza A virus through recognition of
viral RNA. Immunity 30, 556–565 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
98. Thomas, P.G. et al. The intracellular sensor NLRP3 mediates
key innate and healing responses to influenza A virus via the
regulation of caspase-1. Immunity 30, 566–575 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
99. Ichinohe, T., Lee, H.K., Ogura, Y., Flavell, R. & Iwasaki, A.
Inflammasome recognition of influenza virus is essential for
adaptive immune responses. J. Exp. Med. 206, 79–87 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
100. Ichinose, T., Pang, I.K. & Iwasaki, A. Influenza virus activates
inflammasomes through intracellular M2 channel. Nat.
Immunol. advance online publication, doi:10.1038/ni.1861
(11 April 2010).
101. Schulz, O. et al. Toll-like receptor 3 promotes cross-priming
to virus-infected cells. Nature 433, 887–892 (2005).


CAS  PubMed  Google Scholar 
102. Kumar, H., Koyama, S., Ishii, K.J., Kawai, T. & Akira, S.
Cooperation of IPS-1- and TRIF-dependent pathways in poly
IC-enhanced antibody production and cytotoxic T cell
responses. J. Immunol. 180, 683–687 (2008).
CAS  PubMed  Google Scholar 
103. Longhi, M.P. et al. Dendritic cells require a systemic type I
interferon response to mature and induce CD4+ Th1
immunity with poly IC as adjuvant. J. Exp. Med. 206, 1589–
1602 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
104. Schaefer, L. et al. The matrix component biglycan is
proinflammatory and signals through Toll-like receptors 4
and 2 in macrophages. J. Clin. Invest. 115, 2223–2233 (2005).
CAS  PubMed  PubMed Central  Google Scholar 
105. Jiang, D. et al. Regulation of lung injury and repair by Toll-
like receptors and hyaluronan. Nat. Med. 11, 1173–1179
(2005).
CAS  PubMed  Google Scholar 
106. Kim, S. et al. Carcinoma-produced factors activate myeloid
cells through TLR2 to stimulate metastasis. Nature 457, 102–
106 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
107. Okamura, Y. et al. The extra domain A of fibronectin
activates Toll-like receptor 4. J. Biol. Chem. 276, 10229–
10233 (2001).
CAS  PubMed  Google Scholar 
108. Guillot, L. et al. Cutting edge: the immunostimulatory activity
of the lung surfactant protein-A involves Toll-like receptor 4.


J. Immunol. 168, 5989–5992 (2002).
CAS  PubMed  Google Scholar 
109. Yang, H. & Tracey, K.J. Targeting HMGB1 in inflammation.
Biochim. Biophys. Acta 1799, 149–156 (2009).
PubMed  PubMed Central  Google Scholar 
110. Tsung, A. et al. The nuclear factor HMGB1 mediates hepatic
injury after murine liver ischemia-reperfusion. J. Exp. Med.
201, 1135–1143 (2005).
CAS  PubMed  PubMed Central  Google Scholar 
111. Yanai, H. et al. HMGB proteins function as universal sentinels
for nucleic-acid-mediated innate immune responses. Nature
462, 99–103 (2009).
CAS  PubMed  Google Scholar 
112. Tsan, M.F. & Gao, B. Heat shock proteins and immune system.
J. Leukoc. Biol. 85, 905–910 (2009).
CAS  PubMed  Google Scholar 
113. Stewart, C.R. et al. CD36 ligands promote sterile
inflammation through assembly of a Toll-like receptor 4 and
6 heterodimer. Nat. Immunol. 11, 155–161 (2010).
CAS  PubMed  Google Scholar 
114. Biragyn, A. et al. Toll-like receptor 4-dependent activation of
dendritic cells by beta-defensin 2. Science 298, 1025–1029
(2002).
CAS  PubMed  Google Scholar 
115. Imai, Y. et al. Identification of oxidative stress and Toll-like
receptor 4 signaling as a key pathway of acute lung injury.
Cell 133, 235–249 (2008).


CAS  PubMed  PubMed Central  Google Scholar 
116. Barton, G.M., Kagan, J.C. & Medzhitov, R. Intracellular
localization of Toll-like receptor 9 prevents recognition of self
DNA but facilitates access to viral DNA. Nat. Immunol. 7, 49–
56 (2006).
CAS  PubMed  Google Scholar 
117. Marshak-Rothstein, A. & Rifkin, I.R. Immunologically active
autoantigens: the role of Toll-like receptors in the
development of chronic inflammatory disease. Annu. Rev.
Immunol. 25, 419–441 (2007).
CAS  PubMed  Google Scholar 
118. Means, T.K. et al. Human lupus autoantibody-DNA complexes
activate DCs through cooperation of CD32 and TLR9. J. Clin.
Invest. 115, 407–417 (2005).
CAS  PubMed  PubMed Central  Google Scholar 
119. Vollmer, J. et al. Immune stimulation mediated by
autoantigen binding sites within small nuclear RNAs involves
Toll-like receptors 7 and 8. J. Exp. Med. 202, 1575–1585
(2005).
CAS  PubMed  PubMed Central  Google Scholar 
120. Viglianti, G.A. et al. Activation of autoreactive B cells by CpG
dsDNA. Immunity 19, 837–847 (2003).
CAS  PubMed  Google Scholar 
121. Tian, J. et al. Toll-like receptor 9-dependent activation by
DNA-containing immune complexes is mediated by HMGB1
and RAGE. Nat. Immunol. 8, 487–496 (2007).
CAS  PubMed  Google Scholar 
122. Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA
coupled with antimicrobial peptide. Nature 449, 564–569


(2007).
CAS  PubMed  Google Scholar 
123. Ganguly, D. et al. Self-RNA-antimicrobial peptide complexes
activate human dendritic cells through TLR7 and TLR8. J.
Exp. Med. 206, 1983–1994 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
124. Pisitkun, P. et al. Autoreactive B cell responses to RNA-
related antigens due to TLR7 gene duplication. Science 312,
1669–1672 (2006).
CAS  PubMed  Google Scholar 
125. Fairhurst, A.M. et al. Yaa autoimmune phenotypes are
conferred by overexpression of TLR7. Eur. J. Immunol. 38,
1971–1978 (2008).
CAS  PubMed  PubMed Central  Google Scholar 
126. Lee, P.Y. et al. TLR7-dependent and FcγR-independent
production of type I interferon in experimental mouse lupus.
J. Exp. Med. 205, 2995–3006 (2008).
CAS  PubMed  PubMed Central  Google Scholar 
127. Christensen, S.R. et al. Toll-like receptor 7 and TLR9 dictate
autoantibody specificity and have opposing inflammatory and
regulatory roles in a murine model of lupus. Immunity 25,
417–428 (2006).
CAS  PubMed  Google Scholar 
128. Napirei, M. et al. Features of systemic lupus erythematosus in
Dnase1-deficient mice. Nat. Genet. 25, 177–181 (2000).
CAS  PubMed  Google Scholar 
129. Yasutomo, K. et al. Mutation of DNASE1 in people with
systemic lupus erythematosus. Nat. Genet. 28, 313–314


(2001).
CAS  PubMed  Google Scholar 
130. Kawane, K. et al. Chronic polyarthritis caused by mammalian
DNA that escapes from degradation in macrophages. Nature
443, 998–1002 (2006).
CAS  PubMed  Google Scholar 
131. Crow, Y.J. et al. Mutations in the gene encoding the 3′-5′
DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at
the AGS1 locus. Nat. Genet. 38, 917–920 (2006).
CAS  PubMed  Google Scholar 
132. Lee-Kirsch, M.A. et al. Mutations in the gene encoding the
3′-5′ DNA exonuclease TREX1 are associated with systemic
lupus erythematosus. Nat. Genet. 39, 1065–1067 (2007).
CAS  PubMed  Google Scholar 
133. Stetson, D.B., Ko, J.S., Heidmann, T. & Medzhitov, R. Trex1
prevents cell-intrinsic initiation of autoimmunity. Cell 134,
587–598 (2008).
CAS  PubMed  PubMed Central  Google Scholar 
134. Zheng, L. et al. Fen1 mutations result in autoimmunity,
chronic inflammation and cancers. Nat. Med. 13, 812–819
(2007).
CAS  PubMed  Google Scholar 
135. Rice, G.I. et al. Mutations involved in Aicardi-Goutieres
syndrome implicate SAMHD1 as regulator of the innate
immune response. Nat. Genet. 41, 829–832 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
136. Amit, I. et al. Unbiased reconstruction of a mammalian
transcriptional network mediating pathogen responses.


Science 326, 257–263 (2009).
CAS  PubMed  PubMed Central  Google Scholar 
Download references
Acknowledgements
We thank E. Kamada for secretarial assistance. Supported by the
Special Coordination Funds of the Japanese Ministry of Education,
Culture, Sports, Science and Technology, the 21st Century Center of
Excellence Program of Japan and the National Institutes of Health
(P01 AI070167).
Author information
Authors and Affiliations
1. Laboratory of Host Defense, World Premier International
Immunology Frontier Research Center, Osaka University,
Osaka, Japan
Taro Kawai & Shizuo Akira
2. Department of Host Defense, Research Institute for Microbial
Diseases, Osaka University, Osaka, Japan
Taro Kawai & Shizuo Akira
Authors
1. Taro Kawai
View author publications
Search author on:PubMed Google Scholar
2. Shizuo Akira
View author publications


Search author on:PubMed Google Scholar
Corresponding author
Correspondence to Shizuo Akira.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
Reprints and permissions
About this article
Cite this article
Kawai, T., Akira, S. The role of pattern-recognition receptors in
innate immunity: update on Toll-like receptors. Nat Immunol 11,
373–384 (2010). https://doi.org/10.1038/ni.1863
Download citation
•  Published: 20 April 2010
•  Issue date: May 2010
•  DOI: https://doi.org/10.1038/ni.1863
Share this article
Anyone you share the following link with will be able to read this
content:


Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
•  Understanding immune microenvironment
alterations in the brain to improve the diagnosis
and treatment of diverse brain diseases
○  Xiaotong Xu
○  Yi Han
○  Sijin Liu
Cell Communication and Signaling (2024)
•  Exploring the genetic factors behind the
discrepancy in resistance to bovine tuberculosis
between African zebu cattle and European
taurine cattle
○  SangJung Lee
○  Charton Clémentine
○  Heebal Kim
Scientific Reports (2024)
•  Formation of memory assemblies through the
DNA-sensing TLR9 pathway
○  Vladimir Jovasevic
○  Elizabeth M. Wood
○  Jelena Radulovic


Nature (2024)
•  Cyclical palmitoylation regulates TLR9 signalling
and systemic autoimmunity in mice
○  Hai Ni
○  Yinuo Wang
○  Jijun Zhao
Nature Communications (2024)
•  Low-Intensity Pulsed Ultrasound: A Physical
Stimulus with Immunomodulatory and Anti-
inflammatory Potential
○  Wenxin Liang
○  Beibei Liang
○  Yun Cai
Annals of Biomedical Engineering (2024)
 Access through your institution
Buy or subscribe
Advertisement
[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Videos
•  Current issue
•  Collections
•  Follow us on Twitter


•  Subscribe
•  Sign up for alerts
•  RSS feed
About the journal
•  Aims & Scope
•  Journal Information
•  Journal Metrics
•  About the Editors
•  Research Cross-Journal Editorial Team
•  Reviews Cross-Journal Editorial Team
•  Our publishing models
•  Editorial Values Statement
•  Editorial Policies
•  Content Types
•  Web Feeds
•  Posters
•  Contact
Publish with us
•  Submission Guidelines
•  For Reviewers
•  Language editing services
•  Open access funding
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search


Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies
Nature Immunology (Nat Immunol)
ISSN 1529-2916 (online)
ISSN 1529-2908 (print)
nature.com sitemap
About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content
•  Journals A-Z
•  Articles by subject
•  protocols.io
•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services


•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services
•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites
•  Nature Africa
•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement


•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


 Close
[image]
Sign up for the Nature Briefing newsletter — what matters in
science, free to your inbox daily.
Email address
Sign up
I agree my information will be processed in accordance with the
Nature and Springer Nature Limited Privacy Policy.
 Close
Get the most important science stories of the day, free in your
inbox. Sign up for Nature Briefing
[image]


